Loading
Everything in development, the medicines held by this cancer's subtypes, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for HER2-positive breast cancer with brain metastases, drawn from the whole corpus: 9 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
No randomised trial has compared systemic therapy first with radiosurgery first for asymptomatic lesions.
Leptomeningeal disease still has no proven treatment.
Background: HER2-positive brain metastases. Also on OnCo: Atlas of advanced disease · How cancer spreads: the metastasis stages.
Radionecrosis after radiosurgery may be commoner with antibody-drug conjugates.
Screening MRI might find lesions earlier but no trial shows it helps.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Symptoms and red flags · Early detection roadmap.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 17 changes by month →When this page itself was last checked or edited.
PFS 24.
A milestone in how this cancer is treated.
CNS ORR 71.
A milestone in how this cancer is treated.
PFS 9.